Translational Development Acquisition Corp. (NASDAQ:TDACU – Get Free Report) was the recipient of a large drop in short interest in the month of September. As of September 30th, there was short interest totaling 3 shares, a drop of 50.0% from the September 15th total of 6 shares. Based on an average daily volume of 16 shares, the short-interest ratio is currently 0.2 days.
Translational Development Acquisition Price Performance
Shares of NASDAQ TDACU remained flat at $11.48 during trading on Friday. Translational Development Acquisition has a fifty-two week low of $10.71 and a fifty-two week high of $17.29. The stock has a 50-day simple moving average of $12.10 and a 200-day simple moving average of $11.70.
Translational Development Acquisition Company Profile
Translational Development Acquisition Corporation is a special purpose acquisition company (SPAC) formed to identify and complete a business combination with one or more operating companies. Rather than selling products or services of its own, the company raises capital through a public offering and holds those funds while it evaluates potential merger, acquisition, or similar opportunities.
The company has indicated that it is seeking a target in the healthcare and life sciences sectors, although its business activities may change substantially if it completes a transaction.
See Also
- Five stocks we like better than Translational Development Acquisition
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
